Dulcolax and Shock haemorrhagic - a phase IV clinical study of FDA data

Summary:

Shock haemorrhagic is reported as a side effect among people who take Dulcolax (bisacodyl), especially for people who are male, 60+ old, also take Tylenol, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Shock haemorrhagic when taking Dulcolax. It is created by eHealthMe based on reports of 12,769 people who have side effects when taking Dulcolax from the FDA, and is updated regularly.

What is Dulcolax?

Dulcolax has active ingredients of bisacodyl. It is often used in constipation. eHealthMe is studying from 12,897 Dulcolax users. Check the latest studies of Dulcolax.

What is Shock haemorrhagic?

Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding) is found to be associated with 654 drugs and 800 conditions by eHealthMe. Check the latest studies of Shock haemorrhagic.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 21, 2026

12,769 people reported to have side effects when taking Dulcolax.
Among them, 14 people (0.11%) have Shock haemorrhagic.

Could Dulcolax cause Shock haemorrhagic?

Among these 14 people:

What is the gender of people who have Shock haemorrhagic when taking Dulcolax? *

female: 50 %
male: 50 %

What is the age of people who have Shock haemorrhagic when taking Dulcolax? *

What are other drugs people take besides Dulcolax? *

What are other side effects people have besides Shock haemorrhagic? *

Pulmonary Haematoma (collection of blood within the tissue of the lung): 3 people, 21.43%
Anaemia (lack of blood): 3 people, 21.43%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 3 people, 21.43%
Rib Fracture: 3 people, 21.43%
Fall: 3 people, 21.43%
Spinal Compression Fracture (fracture due to spinal compression on bone): 3 people, 21.43%
Scapula Fracture (a fracture of the scapula, the shoulder blade): 3 people, 21.43%
Haemothorax (collection of blood in the pleural space (the space between the lungs and the walls of the chest)): 3 people, 21.43%
Multiple Injuries: 2 people, 14.29%
Haemorrhagic Anaemia (anaemia due to excessive bleeding): 2 people, 14.29%

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 42.86%
Stress And Anxiety: 2 people, 14.29%
Sleep Disorder: 2 people, 14.29%
High Blood Pressure: 2 people, 14.29%
Pain: 1 person, 7.14%
Neuropathy Peripheral (surface nerve damage): 1 person, 7.14%
Procedural Pain: 1 person, 7.14%
Bone Disorder: 1 person, 7.14%
Bone Pain: 1 person, 7.14%
Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Dulcolax and have Shock haemorrhagic?

- Check whether Shock haemorrhagic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dulcolax:

Dulcolax (12,897 reports)

Browse all side effects of Dulcolax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Shock haemorrhagic:

Shock haemorrhagic (654 drugs)

Browse all the conditions that are associated with Shock haemorrhagic:

Shock haemorrhagic (800 conditions)

Related publications that referenced our studies

Hwabejire JO, Lu J, Liu B, Li Y, Halaweish I, Alam HB, "Valproic acid for the treatment of hemorrhagic shock: a dose-optimization study", journal of surgical research, 2014 Jan .
Hwabejire JO, Lu J, Liu B, Li Y, Halaweish I, Alam HB, "Valproic acid for the treatment of hemorrhagic shock: a dose-optimization study", journal of surgical research, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on bisacodyl (the active ingredients of Dulcolax) and Dulcolax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.